Gene Pharmaceutical's Babaeski Solar Power Project Environmental Impact Assessment Process Has Begun

The Environmental Impact Assessment (EIA) process for the Gen İlaç Babaeski Solar Power Plant project has commenced. According to a statement made on the website of the General Directorate of Environmental Impact Assessment, Permission, and Supervision, the following information was provided: "The Gen İlaç and Health Products (IS:GENIL) San. ve Tic. A.Ş. plans to develop the Gen İlaç Babaeski Solar Power Plant (2.475 MWe / 2.93706 MWm-3.79 ha) located in the Kumrular neighborhood of Babaeski, Kırklareli, on parcels 61-683-684 of 102 island. The provided project file has been reviewed in accordance with Article 16 of the Environmental Impact Assessment Regulation, and the EIA process for the project has begun."